Related Experiment Video
Updated: May 15, 2026

07:51
Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
Published on: May 21, 2015
IFPA Senior Award Lecture: Reproductive immunology in perspective--reprogramming at the maternal-fetal interface.
1Department of Anatomy and Cell Biology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA.
Placenta
|January 9, 2013
Summary
The placenta reprograms maternal immune cells during pregnancy, creating an immunosuppressive uterine environment. Soluble HLA-G from trophoblasts programs placental macrophages, protecting the fetus.
Area of Science:
- Reproductive immunology
- Maternal-fetal interface immunology
- Pregnancy immune adaptation
Background:
- Historically, maternal and fetal immune interactions during pregnancy were underappreciated.
- Current understanding recognizes significant immune reprogramming in the uterus upon pregnancy initiation.
- Mammalian uteri develop an immunosuppressive environment to accommodate the genetically distinct fetus.
Discussion:
- The placenta is proposed as the primary mediator of uterine immune reprogramming throughout gestation.
- Trophoblast-derived soluble human leukocyte antigen-G (sHLA-G) is investigated for its role in modulating uterine immune cells.
- Soluble HLA-G influences uterine placental macrophages, which are typically cytotoxic.
Key Insights:
- Soluble HLA-G plays a crucial role in programming uterine placental macrophages.
- This programming converts potentially destructive immune cells into a supportive role.
- Placental sHLA-G is vital for maintaining a protective, immunosuppressive uterine environment.
Outlook:
- Further research into sHLA-G's mechanisms can elucidate pregnancy maintenance strategies.
- Understanding this immune dialogue is key to addressing pregnancy complications.
- Targeting placental immune modulation may offer therapeutic avenues for reproductive health.
More Related Videos
Related Concept Videos
Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.
Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Infertility in Females
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Endometriosis, a condition characterized by abnormal growth of endometrial...
Reproductive Cloning
Reproductive cloning is the process of producing a genetically identical copy—a clone—of an entire organism. While clones can be produced by splitting an early embryo—similar to what happens naturally with identical twins—cloning of adult animals is usually done by a process called somatic cell nuclear transfer (SCNT).
Somatic Cell Nuclear Transfer
In SCNT, an egg cell is taken from an animal and its nucleus is removed, creating an enucleated egg. Then a somatic cell—any cell that is not a sex...
Somatic Cell Nuclear Transfer
In SCNT, an egg cell is taken from an animal and its nucleus is removed, creating an enucleated egg. Then a somatic cell—any cell that is not a sex...
Reproductive Cloning
Reproductive cloning is the process of producing a genetically identical copy—a clone—of an entire organism. While clones can be produced by splitting an early embryo—similar to what happens naturally with identical twins—cloning of adult animals is usually done by a process called somatic cell nuclear transfer (SCNT).
Somatic Cell Nuclear Transfer
In SCNT, an egg cell is taken from an animal and its nucleus is removed, creating an enucleated egg. Then a somatic cell—any cell that is not a sex...
Somatic Cell Nuclear Transfer
In SCNT, an egg cell is taken from an animal and its nucleus is removed, creating an enucleated egg. Then a somatic cell—any cell that is not a sex...

